WELLS FARGO & COMPANY/MN - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$351,294
+26.4%
365,931
-1.3%
0.00%
Q1 2023$277,999
+97.3%
370,665
-3.0%
0.00%
Q4 2022$140,876
-23.9%
382,296
-11.2%
0.00%
Q3 2022$185,000
-45.6%
430,374
-1.2%
0.00%
Q2 2022$340,000
-43.2%
435,522
-6.1%
0.00%
Q1 2022$599,000
-13.3%
463,857
-14.8%
0.00%
Q4 2021$691,000
-42.1%
544,128
-0.7%
0.00%
Q3 2021$1,194,000
-43.9%
548,008
-3.5%
0.00%
Q2 2021$2,130,000
-6.2%
568,008
-18.5%
0.00%
-100.0%
Q1 2021$2,272,000
+2.0%
696,994
+6.7%
0.00%0.0%
Q4 2020$2,228,000
-14.6%
653,306
+2.2%
0.00%0.0%
Q3 2020$2,609,000
+20.8%
639,327
-0.0%
0.00%0.0%
Q2 2020$2,160,000
+48.7%
639,421
+2.5%
0.00%0.0%
Q1 2020$1,453,000
-36.1%
624,012
-0.2%
0.00%0.0%
Q4 2019$2,275,000
-60.8%
625,106
-10.6%
0.00%
-50.0%
Q3 2019$5,799,000
+0.5%
699,150
+4.4%
0.00%0.0%
Q2 2019$5,768,000
-19.2%
669,922
+0.3%
0.00%0.0%
Q1 2019$7,141,000
+21.7%
667,915
-0.4%
0.00%0.0%
Q4 2018$5,868,000
-55.4%
670,617
-14.3%
0.00%
-50.0%
Q3 2018$13,149,000
-42.0%
782,701
-27.6%
0.00%
-42.9%
Q2 2018$22,652,000
+37.1%
1,080,740
+5.3%
0.01%
+40.0%
Q1 2018$16,521,000
-10.5%
1,026,792
+5.4%
0.01%0.0%
Q4 2017$18,454,000
+38.2%
973,812
+2.6%
0.01%
+25.0%
Q3 2017$13,357,000
+133.2%
949,290
+23.5%
0.00%
+100.0%
Q2 2017$5,727,000
+43.3%
768,658
+25.1%
0.00%
+100.0%
Q1 2017$3,996,000
+51.5%
614,610
+3.3%
0.00%0.0%
Q4 2016$2,637,000
-6.2%
595,149
-1.1%
0.00%0.0%
Q3 2016$2,811,000
-26.0%
602,031
+4.1%
0.00%0.0%
Q2 2016$3,799,000
+4.9%
578,205
+1.5%
0.00%0.0%
Q1 2016$3,623,000
+5.8%
569,654
+0.3%
0.00%0.0%
Q4 2015$3,424,000
+0.3%
567,809
-0.5%
0.00%0.0%
Q3 2015$3,414,000
-13.4%
570,773
-1.0%
0.00%
-50.0%
Q2 2015$3,943,000
-37.8%
576,429
-44.8%
0.00%
+100.0%
Q1 2015$6,338,000
+95.4%
1,044,398
+82.2%
0.00%0.0%
Q4 2014$3,244,000
-19.2%
573,154
+16.2%
0.00%
-50.0%
Q3 2014$4,015,000
+119.3%
493,166
+119.0%
0.00%
+100.0%
Q2 2014$1,831,000
+125.5%
225,178
+117.5%
0.00%
Q1 2014$812,000
+5.9%
103,512
+19.4%
0.00%
Q4 2013$767,000
-15.9%
86,712
-20.3%
0.00%
Q3 2013$912,000
+19.7%
108,865
+6.6%
0.00%
Q2 2013$762,000102,1700.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders